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Background: We investigated a potential link between genetic polymorphisms in genes XRCC1 (Arg399Gln),
OGG1 (Ser326Cys), XRCC3 (Thr241Met), and XRCC4 (Ile401Thr) with the level of DNA damage and repair, accessed
by comet and micronucleus test, in 51 COPD patients and 51 controls.
Methods: Peripheral blood was used to perform the alkaline and neutral comet assay; and genetic polymorphisms
by PCR/RFLP. To assess the susceptibility to exogenous DNA damage, the cells were treated with methyl
methanesulphonate for 1-h or 3-h. After 3-h treatment the % residual damage was calculated assuming the value
of 1-h treatment as 100%. The cytogenetic damage was evaluated by buccal micronucleus cytome assay (BMCyt).
Results: COPD patients with the risk allele XRCC1 (Arg399Gln) and XRCC3 (Thr241Met) showed higher DNA damage
by comet assay. The residual damage was higher for COPD with risk allele in the four genes. In COPD patients was
showed negative correlation between BMCyt (binucleated, nuclear bud, condensed chromatin and karyorrhexic
cells) with pulmonary function and some variant genotypes.
Conclusion: Our results suggest a possible association between variant genotypes in XRCC1 (Arg399Gln), OGG1
(Ser326Cys), XRCC3 (Thr241Met), and XRCC4 (Ile401Thr), DNA damage and progression of COPD.
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Recently genetic association studies on chronic obstructive
pulmonary disease (COPD) risk have focused on identify-
ing effects of single nucleotide polymorphisms/haplotypes
in candidate genes, among which DNA repair genes are
increasingly studied because of their critical role in
maintaining genome integrity [1]. Assays that measure
DNA repair capacity suggest that it can vary widely
among individuals. Previous investigations reported lower
DNA repair capacity in COPD patients [1-3]. The finding
supports the hypothesis that variants in DNA repair genes
could affect COPD susceptibility. In general, studies are
needed to elucidate the mechanisms by which genes are* Correspondence: andreag@unisc.br
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reproduction in any medium, provided the orinvolved in the development of COPD, lung cancer, or
both as well as to understand of damage recognition and
mechanism of DNA repair [2,4].
The DNA repair system consists of several distinct
pathways, including the base excision repair (BER) pathway
and double-strand break (DSB) repair process [5]. BER
pathway is a DNA repair process which operates on small
lesions such as oxidized or reduced bases, fragmented
or non-bulky adducts, or those produced by methylating
agents and still acting on bases deamination injury
induced by environmental carcinogens or endogenous
sources [1,2,6]. The genes encoding three key enzymes in
this repair pathway are: 8-oxoguanine DNA glycosylase
(OGG1), apurinic/apyrimidinic endonuclease (APE1/APE
X1), and the X-ray repair cross complementing group 1
(XRCC1). OGG1 and XRCC1 play a central role in the BER
pathway. OGG1 catalyzes the removal of 8-hydrodeoxy-
guanine (8-OHdG), which has been considered as a key
biomarker of oxidative DNA damage. The substitution ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with a significant reduction in the repair capacity [6].
Evidence has emerged to support that BER deficiency is
an important contributing factor to cancer susceptibility,
as shown in both animal models and human studies [1,2].
Hence, OGG1 and XRCC1 are suggested to exert com-
bined effect on the development of COPD, and XRCC1
coordinates and stimulates the OGG1 activity [6].
Double-stranded breaks are repaired by two pathways:
homologous recombination (HR) and non-homologous
DNA end joining (NHEJ) [7]. NHEJ is an intrinsically
error-prone pathway while HR results in an free error
repair [8]. HR and NHEJ pathways may have overlapping
functions to maintain chromosomal integrity in eukary-
otes [9]. X-ray repair cross complementing-3 (XRCC3) is
involved in the homologous recombination pathway of
DNA DSB-repair [10] and the role XRCC3 gene have been
most extensively studied due to their influences in the
individual sensitivity to radiation exposure and induction
of DNA damage. The X-ray repair cross complementing-4
(XRCC4) gene functions in the repair of DNA double-
strand is also important [11] and the XRCC4 inactivation
is related to programmed cell death or apoptosis [5].
The cellular processes of DNA damage induction and
repair are fundamental for the maintenance of genome
integrity, and the modulation of these processes can
dramatically increase individual susceptibility to cancer
[12,13]. Comet assay has been used in various studies to
investigate the DNA damage in connection with various
diseases because it is a rapid, simple, and sensitive tech-
nique for measuring DNA breaks and repair in single
cells [14-16]. The cytogenetic damage evaluated by buccal
micronucleus cytome assay (BMCyt) is a sensitive bio-
marker that is widely accepted for chromosome damage
evaluation [17]. The buccal epithelial cells are the first
barrier for the inhalation or ingestion route that can
metabolize proximate carcinogens to reactive products.
About 90% of the human cancers originate from epithelial
cells. Therefore, oral epithelial cells represent a preferred
target site for early genotoxic events induced by carcino-
genic agents entering the body.
We aimed to investigate a potential effect of genetic
polymorphisms in genes XRCC1 (Arg399Gln), OGG1 (Ser
326Cys), XRCC3 (Thr241Met), and XRCC4 (Ile401Thr)
on the level of DNA damage and repair in COPD patients
and controls. Accordingly, we intend to understand the
role of genetic polymorphisms in the modulation of DNA
damage and progression of COPD.
Methods
Fifty-one COPD patients, treated at Santa Cruz Hospital
by the Research Group for Health Rehabilitation, Santa
Cruz do Sul, RS, Brazil were included in this study.
COPD was diagnosed according to the Global Initiativefor Chronic Obstructive Lung Disease guidelines (GOLD)
[18] using clinical history, physical examination, and
presence of airflow obstruction, defined as a ratio of
forced expiratory volume in one second (FEV1) to forced
vital capacity (FVC) less than 70% of predicted value.
The patients were grouped in according to COPD stage
as mild, moderate, severe or very severe [19]. The COPD
patients were matched by gender, age and body mass
index (BMI) with 51 controls without pulmonary disease.
The study protocol was approved by the Ethics Com-
mittee of the University of Santa Cruz do Sul, protocol
number 2011/08. All individuals answered the personal
health questionnaire and signed informed consent before
the interview.
Obtaining sample
The peripheral blood (10 mL) samples were collected
early in the morning from fasted COPD patients and
controls into tubes with EDTA, and used to comet assay
and genetic polymorphisms identification. Buccal cell
samples were collected and processed in accordance
with Thomas et al. [20]. For each subject were prepared
two tubes for left cheek (LC) and right cheek (RC) cells,
each containing methanol. The cells were collected rotat-
ing a cytobrush 20 times in a spiral motion against the
inner surface of the cheek wall. The head of cytobrush
was placed into the tube respective with methanol.
DNA damage evaluation by comet assay
The comet assay was performed under alkaline (detects
single- and double-DNA strand breaks and alkali-labile
sites) and neutral (detects double breaks) conditions
according to the procedure of Singh et al. [21] with the
modifications by Tice et al. [22]. Aliquots of 10 μl freshly
collected whole blood were embedded in 90 μl of 0.75%
low melting agarose, and after agarose solidified slides
were placed in lyses buffer (2.5 M NaCl, 100 mM EDTA,
10 mM Tris; 10% DMSO; pH 10.0-10.5) containing freshly
added 1% (v/v) Triton X-100 and 10% (v/v) dimethyl sul-
phoxide for maximum of 2 weeks. After treatment with
lyses buffer slides and placed fresh prepared alkaline buf-
fer solution (200 mM NaOH and 1 mM EDTA; pH >
13), for 20 min, and DNA submitted of denaturation
and 15 min electrophoresis time were used (0.90 V/cm
and 300 mA). For the neutral condition (3 M sodium
acetate and 1 M Tris; pH=8.5), the denaturation time of
1-h and electrophoresis time of 1-h were used (0.5 V/cm
and 12 mA) [23]. In both versions of the comet assay, after
electrophoresis, the slides were neutralized with 0.4 M
Tris (pH 7.5) and the DNA fixed and stained with silver
nitrate in accordance to Nadin et al. [24]. Images of
100 randomly selected cells (50 cells from each of two
replicate slides) were analyzed for each individual using a
conventional microscope. Two parameters were evaluated
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recommendations for the comet assay consider that visual
scoring of comets is a well-validated evaluation method
[22,26]. Damage index thus ranged from 0 (completely
undamaged: 100 cells × 0) to 400 (with maximum damage:
100 cells × 4).
Comet assay to assess the susceptibility to exogenous
DNA damage
For the assessment of susceptibility to exogenous DNA
damage, whole blood cells were treated with methylme-
thane sulfonate alkylating agent (MMS; 80 μM) for 1-h
or 3-h at 37°C prior to slide preparation, and proceeded
up the steps of the alkaline comet assay as described
above. The percentage of residual DNA damage after 3-
h MMS treatment was calculated using the value of 1-h
MMS treatment for each subject as 100%.
Buccal micronucleus cytome assay (BMCyt)
The cell suspensions were stored at 4°C, until processing.
Afterwards, the cells were centrifuged and the supernatant
was aspirated and added if more buccal cell fixation buffer.
To further cellular disaggregation 5% of DMSO was added
to each of cell suspension. The fixed cells were hydrolyzed
in HCl and stained according Feulgen method [20]. The
scoring criteria for the distinct cell types and nuclear
anomalies in the BMCyt assay were intended for classify-
ing buccal cells into categories that distinguish between
‘normal’ cells (Basal cell) and cells that are considered
‘abnormal’ on the basis of cytological and nuclear features,
indicative of DNA damage (Micronucleated-MN; Nuclear
Bud- BUD), cytokinesis failure (Binucleated-BI) or cell death
(Condensed chromatin-CC; Karyorrhectic-KR; Pyknotic-PY;
Karyolytic- KL). Two thousand cells per sample were scored
to determine the frequency of these cell types [20].
DNA extraction and genotyping
Genomic DNA was isolated from whole blood by the
salting out method [27]. Four polymorphic markers were
investigated by genotyping using the polymerase chain
reaction (PCR) – restriction fragment length polymorph-Table 1 Amplification conditions, restriction enzymes anneali
Gene Primer sequence SNP AT (°C) R
OGG1 3'GTGGATTCTCATCGGTTCG 5' Ser326Cys 58
5'CTGTTGCTGTCGAGAATGC 3'
XRCC1 3'CAAGTACAGCCAGGTCCTAG 5' Arg399Gln 58
5'CCTTCCCTCATCTGGAGTAC 3'
XRCC3 3'GCCTGGTGGTCATCGACTC 5' Thr241Met 67
5'ACAGGGCTCTGGACAGCTCACGTCAC 3'
XRCC4 3'CTCAGAAGAAATTGTGTATGCT 5' Ile401Thr 52
5'ACCACAAGCAAACTGTGTACAC 3'
SNP, single-nucleotide polymorphism; AT, annealing temperature in degrees Celsiusism (RFLP) method. In the Table 1 were show the primers
pairs used, annealing temperature, fragment size and
restriction enzyme of the genes studied [28-31]. All diges-
tion were conducted with a total volume of 15 μL for 18 h
at 37°C and subsequently analyzed on a 3% agarose gel
with ethidium bromide staining.
Statistical analysis
The statistical analyses were performed using the Statis-
tical Package SPSS 18.0. A statistically significant value
was considered when p ≤ 0.05. Demographic data were
presented as mean ± standard deviation. The Mann–
Whitney U test was used to compare the means and the
chi-square test to compare the proportions of categorical
variables in the patients and controls. The distributions
of genotypes for each polymorphic site were tested to
match the Hardy-Weinberg heredity equilibrium by
the chi-square test. The comparison among multiple
groups was performed using the nonparametric two-
tailed Kruskal-Wallis test with the Dunn correction for
multiple comparisons.
The Sample size was calculated for DNA damage by
comet assay as the main outcome. Considering a power
of 80% and α = 5%, the estimated sample size was fifty
subjects [32,33].
Results
The general characteristics of COPD patients and control
group are shown in Table 2. The COPD patients and
matched controls were similar in terms of age, gender,
ethnicity and BMI, but differed regarding pulmonary
function (lower among COPD patients), smoking status,
number of cigarettes smoked per year and smoking
duration (higher among COPD patients).
The damage index in the alkaline comet assay (COPD
36.71±25.41 vs Control 26.65±27.96, p=0.005) and in
the neutral comet assay (COPD 47.53±32.45 vs Control
37.49±38.05, p = 0.047) were elevated in COPD patients.
In this sense, the percentage of residual DNA damage after
3-h MMS treatment was higher in COPD compared to
controls (COPD 145.69±74.11 vs Control 54.63±40.32,ng temperature and fragment size of the studied genes
estriction enzyme Fragment sizes (bp) Reference
Fnu4HI 672 Ruyck et al. (2005) [28]
BcnI 268 Chiyomaru et al. (2012) [29]
NcoI 552 Krupa et al. (2009) [30]
BseMI 277 Relton et al. (2004) [31]
; bp, bases pairs.
Table 3 Comet assay effects in COPD and controls
stratified by genetic polymorphisms in base excision
repair (BER), homologous recombination (HR) and
nonhomologous DNA end joining (NHEJ) repair genes
COPD CONTROL p*
BER
Subjects n= 28 n=26
XRCC1-Arg399Gln (ArgGln+GlnGln) (ArgGln+GlnGln)
COMET ASSAY
DI Alkaline 37.29±27.84 21.04±24.45 0.005
DI Neutral 46.50±41.42 29.00±34.46 0.049
DI Residual 150.89±87.99 51.88±44.20 0.000
Subjects n= 13 n=15
OGG1- Ser326Cys (SerCys+CysCys) (SerCys+CysCys)
COMET ASSAY
DI Alkaline 45.54±30.36 41.60±35.05 NS
DI Neutral 60.54±31.63 55.27±47.68 NS
DI Residual 142.38±92.56 56.00±34.98 0.001
HR and NHEJ
Subjects n= 36 n=36
XRCC 3-Thr241Met (ThrMet+MetMet) (ThrMet+MetMet)
COMET ASSAY
DI Alkaline 36.56±24.67 22.50±23.49 0.009
DI Neutral 48.50±30.55 34.53±37.79 0.039
DI Residual 134.75±77.16 54.06±42.88 0.000
Subjects n= 11 n=07
XRCC 4-Ile401Thr (IIeThr+ThrThr) (IIeThr+ThrThr)
COMET ASSAY
DI Alkaline 36.64±23.80 22.36±24.10 NS
DI Neutral 47.36±28.15 36.43±37.30 NS
DI Residual 134.50±80.74 49.02±36.07 0.013
Data are presented as mean ± SD; DI, damage index; NS, nonsignificant;*
Kruskal- Wallis Test.
Table 2 General and clinical characteristic in the COPD
patients and control group
COPD Control p value for
n = 51 n = 51 Mann–Whitney
test
Gender (male) 30 28 >0.05
Ethnicity (white) 45 50 >0.05
Age (years)a 65.33 ± 8.91 63.61 ± 9.40 >0.05
BMI (kg/m2)a 25.75 ± 5.71 26.82 ± 3.89 >0.05




















>30 years 36 9 χ2 0.000
COPD Statusc
Mild 8 - -
Moderate 16 - -
Severe 16 - -
Very Severe 11 - -
n, sample number; aData are presented as mean ± SD; bMedian
(minimum-maximum); cCOPD status by GOLD [11] ; BMI, body mass index; χ2,
chi-square test.
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(i.e. ≥ 30 cigarettes per day) and light smokers (i.e. < 30
cigarettes per day) and non-smokers accordance to
literature [17,34-38]. In our results no significant dif-
ference was found among heavy smokers, only between
non-smokers and light smokers (i.e. COPD showed
higher DNA damage) for DNA damage index. For BMCyt,
no statistically significant difference was measured
between case and control group.
No statistical difference was observed between COPD
and control group for allelic frequency of 399Gln XRCC1
(0.343 vs 0.314), 326Cys OGG1 (0.166 vs 0.200), 241Met
XRCC3 (0.461 vs 0.500), and 401Thr XRCC4 (0.132 vs
0.098) for homozygous genotype. The distribution of
allelic frequencies in patients and controls was similar
to that found in other population studies in relation to
XRCC1 (Arg399Gln) [6,39,40], XRCC3 (Thr241Met)
[39], and XRCC4 (Ile401Thr) [41], but lower for OGG1
(Ser326Cys) [6]. Then, we evaluated the combination of
variant genotypes according to the presence of the risk
allele. The results are shown in the Table 3. This tableshows the effect of risk alleles of the repair genes in
BER, HR and NHEJ on the level of different comet assay
in COPD and control group.
The DNA damage and residual damage were signifi-
cantly higher in COPD patients presenting the variant
genetic polymorphism in XRCC1 (Arg399Gln) and XRCC3
(Thr241Met) than in control group, as viewed by comet
assay. The XRCC4 (Ile401Thr) and OGG1 (ser326Cys) risk
alleles seem to influence only the COPD patient’s residual
damage induced by MMS.
No significant difference was observed between groups
regarding the frequency of micronuclei and nuclear anom-
alies by BMCyt assay. So, in order to understand the influ-
ence of these genetic polymorphisms in the modulation
of DNA damage and progression of COPD, we established
a correlation between comet assay and BMCyt assay
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(Table 4).
The alkaline basal damage index in COPD patients
correlated positively with CVF and VEF1 (Figure 1A).
In contrast, negative correlation was found between the
basal DNA damage and % residual damage for deficient
in XRCC1 (Arg399Gln) repair. Disease indicators FEV1
(Figure 1B and 1C) and FVC correlated negatively with the
nuclear anomalies (BUD nuclear, binucleated, condensed
chromatin and karyorrhectic cells) for both deficiencies
in XRCC1 (Arg399Gln) and XRCC3 (Thr241Met) repair.
Discussion
Our results detected increased basal DNA damage in
COPD patients with genetic polymorphisms XRCC1
(Arg399Gln) and XRCC3 (Thr241Met) (Table 3). These
data are in accordance with previous studies [5,6,10]. The
presence of the variant 399Gln in XRCC1 has been shown
to be associated with higher levels of DNA adducts and
higher sister chromatid exchange frequencies [6] as well
as measurable reduced DNA repair capacity and increased
risk of several types of cancers [5]. An association between
the irradiation-specific DNA repair rate and the poly-





% Residual damage- basal DI in alkaline comet assay −0.497
% Residual damage- basal DI in neutral comet assay −0.495
% Residual damage- BI NS
% Residual damage- KR NS
FEV1- basal DI in alkaline comet assay NS
FEV1− CC −0.404
FEV1− KR −0.398
FEV1/ FVC- KR −0.441
FEV1/ FVC- BUD NS
FEV1/ FVC- BI NS
FVC- CC −0.428
FVC- basal DI in alkaline comet assay NS
PY- basal DI in neutral comet assay NS
PY- basal DI in alkaline comet assay NS
Basal cell- CC 0.442
Basal cell- MN NS
Basal cell- BUD NS
Basal cell- KL NS
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; DI, damage
each subject taking the value of DI after 1 h MMS treatment as 100%; BI, Binucleate
Buds cells; PY, Pyknotic cells; MN, Micronuclei; KL, Karyolytic cells. Statistical analysisEuropean population [42]. Genetic polymorphism XRCC3,
which participates in DNA double-strand break repair by
homologous recombination pathway, presents a Thr241-
Met substitution in exon 7, which was found to be associ-
ated with an increase in chromosome deletions using
an in vitro cytogenetic challenge assay [5]. DNA strand
breaks measured by the comet assay are non-specific
indicators of transient DNA damage, reflecting equilib-
rium between damage formation and removal at the
particular sampling time [10]. Thus, genetic differences
in DNA repair genes, which modify the DNA repair
capacity, may directly influence the level of DNA damage
[10]. In contrast to our results, Vodicka [43] found no
association between comet assay damage index and the
XRCC1 (Arg399Gln) and XRCC3 (Thr241Met) polymor-
phisms probably due XRCC1 (Arg399Gln) contribute
partially to DNA repair capacity and the polymorphisms
of other genes could play a role in detecting COPD risk
(e.g. XRCC4 genetic polymorphisms which repairs DNA
double-strand breaks by non-homologous end joining
[NHEJ] and the completion of recombination events)
[11]. Also, XRCC1 (Arg399Gln) and OGG1 (Ser326Cys)
are suggested to exert combined effect on the develop-
ment of COPD (i.e. among current/light smokers), andenes, comet assay and BMCyt assay in COPD patients
OGG1 XRCC3
Risk allele Risk allele
ln) (SerCys+CysCys) (ThrMet+MetMet)
p value Spearman’s rho p value Spearman’s rho p value
0.007 NS NS NS NS
0.007 NS NS NS NS
NS NS NS 0.350 0.036
NS NS NS 0.444 0.007
NS NS NS 0.336 0.045
0.029 NS NS NS NS
0.044 NS NS NS NS
0.024 NS NS −0.408 0.013
NS NS NS −0.357 0.032
NS NS NS −0.328 0.051
0.029 −0.645 0.024 −0.343 0.041
NS NS NS 0.423 0.010
NS −0.643 0.024 NS NS
NS −0.616 0.033 NS NS
0.032 NS NS NS NS
NS NS NS 0.381 0.022
NS NS NS 0.467 0.004
NS −0.666 0.018 −0.359 0.032
index; % Residual damage - calculated for DI after 3 h MMS treatment for
d cells; KR, Karyorrhectic cells; CC, Condensed chromatin cells; BUD, Nuclear
was performed by Spearman Correlation test.







COPD patients with XRCC3 (ThrMet+MetMet)A
DNA damage index























































Figure 1 Correlations between polymorphisms in DNA repair genes, comet assay and BMCyt assay in COPD patients. A) Damage Index
in alkaline Comet assay in blood of COPD patients with variant genotypes in XRCC3 (ThrMet+MetMet). The alkaline basal damage index in COPD
patients correlated positively with VEF1 (r 0.336; p=0.045); B) % Condensed chromatin cells (CC) in COPD patients with variant genotypes in XRCC1
(ArgGln+GlnGln) correlated negatively with VEF1 (r -0.404; p= 0.029); C) % Karyorrhectic cells (KR) in COPD patients XRCC1 (ArgGln+GlnGln) correlated
negatively with VEF1 (r -0.398; p= 0.044). COPD patients - black points. Statistical analysis was performed by Spearman’s rho Test.
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[6]. Results concerning different repair rates between
nonsmokers and smokers are inconsistent and the in-
fluence of polymorphisms in repair gene has not been
established yet [44,45].
DNA effects in the comet assay do not only measure
DNA damage but also indicate the DNA repair capacity of
the subjects studied. In our study an influence of XRCC1
(Arg399Gln), OGG1 (Ser326Cys), XRCC3 (Thr241Met),
and XRCC4 (Ile401Thr) genetic polymorphisms on DNA
repair was found in COPD patients compared to controls,
as shown by residual damage (Table 3). These results are
in agreement with Hanssen-Bauer [46], which reported
that polymorphic variants showed significant and repro-
ducible differences in the pattern of % tail DNA compared
to the XRCC1 Arg/Arg after MMS treatment; initially
lower tail. The differences in the repair profiles of the
XRCC1 variants after MMS treatment could be explained
by reduced recruitment of these XRCC1 and interacting
proteins to sites of DNA damage, reduced ability to make
complexes or interact with DNA glycosylases, and/or
reduced efficiency of excision of damaged bases or reso-
lution of strand break intermediates [46]. XRCC1 and
XRCC4 proteins are physically bound in mammalian
cells with DNA Ligase III and DNA Ligase IV, respectively[47]; XRCC2 and XRCC3 genes, members of an emerging
family of Rad51- related proteins, have been shown to
play an essential role in maintaining chromosome sta-
bility in mammalian cells [47]. The XRCC3 gene is a
family member of Rad51-related genes involved in HR
and has been associated with a higher incidence of
DNA damage [48].
The correlations found in our study showed that the
disease progress characterized by higher frequency of cell
abnormalities indicatives of cytokinesis defect and/or DNA
repair and apoptotic cell death (i.e. Bi, BUD, CC, KR cells)
(Table 4). This is the first study to investigate the differ-
ences in cellular and nuclear morphology aiming identify
potential biomarkers associated with DNA damage, chro-
mosomal instability, cell death, and regenerative potential
in COPD patients. Previous studies showed the persistent
inflammation in COPD patients leads to higher acetylation
of histone resulting in increased transcription of proin-
flammatory genes, steroid resistance, DNA damage, gen-
omic instability and premature aging [49,50]. Possibly,
chromosomal aberrations that directly reflect inappropriate
repair of (induced) DNA damage are better suited than
comet assay effects for the determination of repair cap-
acities in our study. The higher frequency of condensed
chromatin, karyorrhectic, pyknotic and karyolitic cells
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surveillance mechanism, eliminating the buccal cells
with genetic damage [20]. Similar results were found in
studies with subjects exposed to pesticides indicating
chromosomal rearrangement [41]. Other study has dem-
onstrated a relationship between genetic susceptibility and
biomarkers in occupationally exposed populations [51].
Oxidative stress also damages the DNA repair pathways,
such as double-strand break, base excision repair, and
nucleotide excision repair, which further cause DNA
damage. The cellular senescence and inflammation will
form a positive feedback to compromise normal cellular
homeostasis [50].
With our results, it is possible to assume an increase
in the cancer risk analyzing the correlations that we
found between pulmonary function and BMCyt because
elevated binucleated cell ratio may be an indicative of
higher aneuploidy rate which, in turn, is associated with
an increased risk of cancer. The mechanism triggering
nuclear bud formation is unknown but may be related to
the elimination of amplified DNA or DNA repair com-
plexes [20,52,53]. So, in this time, the BMCyt could be
used as a biomarker of monitoring in COPD patients.
However, there are some factors that should be taken
into consideration, as the limited database. The sample
size may not have been large enough to detect certain
differences and there are other genetic polymorphisms
that could also influence the repair capacity and conse-
quently the risk for COPD and other repair pathways
could also influence repair efficiency.
Conclusion
Finally, this investigation suggests that basal DNA dam-
age increases, analyzed by Comet and BMCyt assays,
in COPD patients with variant genotypes in XRCC1
(Arg399Gln) and XRCC3 (Thr241Met). In addition, the
induced DNA damage by MMS increases in COPD pa-
tients with variant genotypes in XRCC1 (Arg399Gln),
OGG1 (Ser326Cys), XRCC3 (Thr241Met) and XRCC4
(Ile401Thr) showing impairment of DNA repair. Some
variant genotypes seem to be related to an increase in
Bi, BUD, CC, KR cells, suggesting their possible influence
on the background levels of this cytogenetic biomarker
and progression of COPD.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ALGdS, DJM, ARdMV and JAPH prepared the draft of the manuscript. All the
authors collected the data and contributed to the interpretation of results
and to the revision of the manuscript. All the authors read and approved the
final manuscript.
Acknowledgments
The authors thank to all volunteers who participated of this study and to the
Biotechnology and Genetics Laboratory - UNISC.Funding
This research was supported by Brazilian Agencies Foundation for Research
Support of Rio Grande do Sul and National Counsel of Technological and
Scientific Development [PRONEX/FAPERGS/CNPq 10/0044-3]; Santa Cruz
Hospital; Research Group Health Rehabilitation and its Interfaces by
University of Santa Cruz do Sul - UNISC; Federal University of Rio Grande do
Sul - UFRGS.
Author details
1Santa Cruz Hospital and Department of Health and Physical Education,
University of Santa Cruz do Sul - UNISC, Avenida Independência, 2293, Bloco
42, Bairro Universitário, Santa Cruz do Sul, RS, Brazil. 2Graduate Program in
Cell and Molecular Biology, Federal University of Rio Grande do Sul - UFRGS,
Porto Alegre, RS, Brazil. 3Scientific Initiation of University of Santa Cruz do
Sul - UNISC, Santa Cruz do Sul, RS, Brazil. 4Department of Biology and
Pharmacy, University of Santa Cruz do Sul - UNISC, Santa Cruz do Sul, RS,
Brazil. 5Laboratory of Genetic Toxicology, Federal University of Health
Sciences of Porto Alegre - UFCSPA, Porto Alegre, RS, Brazil. 6Department of
Biophysics, Federal University of Rio Grande do Sul - UFRGS, Porto Alegre,
RS, Brazil. 7Institute of Biotechnology, University of Caxias do Sul, Caxias do Sul,
RS, Brazil.
Received: 17 May 2013 Accepted: 11 September 2013
Published: 20 September 2013
References
1. Yin J, et al: The DNA repair gene XRCC1 and genetic susceptibility of
lung cancer in a northeastern Chinese population. Lung Cancer 2007,
56(2):153–160.
2. Hang B: Formation and repair of tobacco carcinogen-derived bulky DNA
adducts. J Nucleic Acids 2010, 2010:709521.
3. da Silva ALG, et al: Effect of Physical Exercise on the Level of DNA
Damage in Chronic Obstructive Pulmonary Disease Patients. ISRN
Pulmonology 2013, 2013. Article ID 907520, 8 pages, 2013. doi:10.1155/2013/
907520.
4. de Andrade M, et al: Genetic variants associated with the risk of chronic
obstructive pulmonary disease with and without lung cancer.
Cancer Prev Res (Phila) 2012, 5(3):365–373.
5. Andreassi MG, et al: Genetic polymorphisms in XRCC1, OGG1, APE1 and
XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal
DNA damage in interventional cardiologists. Mutat Res 2009,
666(1–2):57–63.
6. Yang SF, et al: hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms
associated with chronic obstructive pulmonary disease. Chin Med J (Engl)
2009, 122(8):960–966.
7. Mao Z, et al: DNA repair by homologous recombination, but not by
nonhomologous end joining, is elevated in breast cancer cells. Neoplasia
2009, 11(7):683–691.
8. Mao Z, et al: DNA repair by nonhomologous end joining and
homologous recombination during cell cycle in human cells. Cell Cycle
2008, 7(18):2902–2906.
9. Lieber MR: The biochemistry and biological significance of
nonhomologous DNA end joining: an essential repair process in
multicellular eukaryotes. Genes Cells 1999, 4(2):77–85.
10. Hoffmann H, et al: Genetic polymorphisms and the effect of cigarette
smoking in the comet assay. Mutagenesis 2005, 20(5):359–364.
11. Wang Y, et al: Polymorphisms of XRCC4 are involved in reduced
colorectal cancer risk in Chinese schizophrenia patients.
BMC Cancer 2010, 10:523.
12. Tzortzaki EG, et al: Oxidative DNA damage and somatic mutations: a link
to the molecular pathogenesis of chronic inflammatory airway diseases.
Chest 2012, 141(5):1243–1250.
13. Caramori G, et al: Unbalanced oxidant-induced DNA damage and repair
in COPD: a link towards lung cancer. Thorax 2011, 66(6):521–527.
14. Collins A, Harrington V: Repair of oxidative DNA damage: assessing its
contribution to cancer prevention. Mutagenesis 2002, 17(6):489–493.
15. Blasiak J, et al: Basal, oxidative and alkylative DNA damage, DNA repair
efficacy and mutagen sensitivity in breast cancer. Mutat Res 2004,
554(1–2):139–148.
16. Mutlu-Turkoglu U, et al: Increased plasma malondialdehyde and protein
carbonyl levels and lymphocyte DNA damage in patients with
da Silva et al. BMC Medical Genetics 2013, 14:93 Page 8 of 8
http://www.biomedcentral.com/1471-2350/14/93angiographically defined coronary artery disease. Clin Biochem 2005,
38(12):1059–1065.
17. Casella M, et al: No evidence of chromosome damage in chronic
obstructive pulmonary disease (COPD). Mutagenesis 2006, 21(2):167–171.
18. Nagai A, et al: [Guideline for diagnosis and treatment of COPD (chronic
obstructive pulmonary disease). The Third Edition: diagnosis]. Nihon
Kokyuki Gakkai Zasshi 2009, 30(Suppl Copd):32–67.
19. Nagai A, et al: [Guideline for diagnosis and treatment of COPD
(chronic obstructive pulmonary disease). The Third Edition: definition,
epidemiology, risk factors, pathology and etiology]. Nihon Kokyuki Gakkai
Zasshi 2009, 30(Suppl Copd):2–29.
20. Thomas P, et al: Buccal micronucleus cytome assay. Nat Protoc 2009,
4(6):825–837.
21. Singh NP, et al: A simple technique for quantitation of low levels of DNA
damage in individual cells. Exp Cell Res 1988, 175(1):184–191.
22. Tice RR, et al: Single cell gel/comet assay: guidelines for in vitro and in vivo
genetic toxicology testing. Environ Mol Mutagen 2000, 35(3):206–221.
23. Wojewodzka M, Buraczewska I, Kruszewski M: A modified neutral comet
assay: elimination of lysis at high temperature and validation of the assay
with anti-single-stranded DNA antibody. Mutat Res 2002, 518(1):9–20.
24. Nadin SB, Vargas-Roig LM, Ciocca DR: A silver staining method for
single-cell gel assay. J Histochem Cytochem 2001, 49(9):1183–1186.
25. Heuser VD, et al: Evaluation of genetic damage in Brazilian footwear-
workers: biomarkers of exposure, effect, and susceptibility. Toxicology
2007, 232(3):235–247.
26. Collins AR, et al: The comet assay: topical issues. Mutagenesis 2008,
23(3):143–151.
27. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting
DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215.
28. De Ruyck K, et al: Radiation-induced damage to normal tissues after
radiotherapy in patients treated for gynecologic tumors: association with
single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes
and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat
Oncol Biol Phys 2005, 62(4):1140–1149.
29. Chiyomaru K, Nagano T, Nishigori C: XRCC1 Arg194Trp polymorphism, risk
of nonmelanoma skin cancer and extramammary Paget’s disease in a
Japanese population. Arch Dermatol Res 2012, 304(5):363–370.
30. Krupa R, et al: Polymorphism of the homologous recombination repair
genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol 2009, 87(1):32–35.
31. Relton CL, et al: DNA repair gene polymorphisms, pre-natal factors and
the frequency of somatic mutations in the glycophorin-A gene among
healthy newborns. Mutat Res 2004, 545(1–2):49–57.
32. Lwanga SK, Lemeshow S: Sample size determination in health studies: a
practical manual; 1991. Available from: http://www.tbrieder.org/publications/
books_english/lemeshow_samplesize.pdf.
33. SCHLESSELMAN JJ: Case–control studies: design, conduct, analysis. New York:
O.U. Press; 1982.
34. DeMarini DM: Genotoxicity of tobacco smoke and tobacco smoke
condensate: a review. Mutat Res 2004, 567(2–3):447–474.
35. Speit G, et al: Investigations on the effect of cigarette smoking in the
comet assay. Mutat Res 2003, 542(1–2):33–42.
36. Barale R, et al: Sister chromatid exchange and micronucleus frequency in
human lymphocytes of 1,650 subjects in an Italian population: II.
Contribution of sex, age, and lifestyle. Environ Mol Mutagen 1998,
31(3):228–242.
37. da Silva ALG, et al: DNA Damage and Oxidative Stress in Patients with
Chronic Obstructive Pulmonary Disease. The Open Biomarkers Journal
2013: . In press.
38. Bonassi S, et al: Effect of smoking habit on the frequency of micronuclei
in human lymphocytes: results from the Human MicroNucleus project.
Mutat Res 2003, 543(2):155–166.
39. Duarte MC, et al: Polymorphisms of DNA repair genes XRCC1 and XRCC3,
interaction with environmental exposure and risk of chronic gastritis
and gastric cancer. World J Gastroenterol 2005, 11(42):6593–6600.
40. Rossit AR, et al: Polymorphisms in the DNA repair gene XRCC1 and
susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians.
Cancer Lett 2002, 180(2):173–182.
41. Da Silva FR, et al: Genotoxic biomonitoring of tobacco farmers:
Biomarkers of exposure, of early biological effects and of susceptibility.
J Hazard Mater 2012, 225–226:81–90.42. Vodicka P, et al: Genetic polymorphisms in DNA repair genes and
possible links with DNA repair rates, chromosomal aberrations and
single-strand breaks in DNA. Carcinogenesis 2004, 25(5):757–763.
43. Vodicka P, et al: Markers of individual susceptibility and DNA repair rate
in workers exposed to xenobiotics in a tire plant. Environ Mol Mutagen
2004, 44(4):283–292.
44. Popanda O, et al: Specific combinations of DNA repair gene variants and
increased risk for non-small cell lung cancer. Carcinogenesis 2004,
25(12):2433–2441.
45. Vineis P: Individual susceptibility to carcinogens. Oncogene 2004,
23(38):6477–6483.
46. Hanssen-Bauer A, et al: The region of XRCC1 which harbours the three
most common nonsynonymous polymorphic variants, is essential for the
scaffolding function of XRCC1. DNA Repair (Amst) 2012, 11(4):357–366.
47. Yen CY, et al: Combinational polymorphisms of four DNA repair genes
XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer
in Taiwan. J Oral Pathol Med 2008, 37(5):271–277.
48. Bassi C, et al: Efficiency of the DNA repair and polymorphisms of the
XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus
erythematosus. Lupus 2008, 17(11):988–995.
49. Yao H, Rahman I: Role of histone deacetylase 2 in epigenetics and
cellular senescence: implications in lung inflammaging and COPD.
Am J Physiol Lung Cell Mol Physiol 2012, 303(7):L557–L566.
50. Rahman I, et al: SIRT1 as a therapeutic target in inflammaging of the
pulmonary disease. Prev Med 2012, 54(Suppl):S20–S28.
51. Da Silva FR, et al: Application of the buccal micronucleus cytome assay
and analysis of PON1Gln192Arg and CYP2A6*9(−48T>G) polymorphisms
in tobacco farmers. Environ Mol Mutagen 2012, 53(7):525–534.
52. Bonassi S, et al: The HUman MicroNucleus project on eXfoLiated buccal
cells (HUMN(XL)): the role of life-style, host factors, occupational exposures,
health status, and assay protocol. Mutat Res 2011, 728(3):88–97.
53. Migliore L, et al: Association of micronucleus frequency with
neurodegenerative diseases. Mutagenesis 2011, 26(1):85–92.
doi:10.1186/1471-2350-14-93
Cite this article as: da Silva et al.: Evaluation of DNA damage in COPD
patients and its correlation with polymorphisms in repair genes. BMC
Medical Genetics 2013 14:93.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
